Articles Published in 2010

ClearTrial Launches Study Forecasting Service

Tuesday, March 16, 2010 06:30 AM

ClearTrial, a provider of clinical trial software, recently launched its Study Costing and Optimization Service (SCOS), a product that combines ClearTrial’s existing trial management software with the consultation services of the company’s clinical services staff. ClearTrial said the new offering will give smaller biopharma companies more control over clinical trial costs, resources and timelines.

More... »

Covance-Lilly Deal Continues to Bloom

Monday, March 15, 2010 06:51 AM

A little more than a year after Covance entered into a ground-breaking $1.6-billion drug development agreement with Eli Lilly, the contract research organization (CRO) continues to reap the awards of that deal and recently expanded the relationship.

More... »

INC Research Provides ePRO Services Through Invivodata Partnership

Friday, March 12, 2010 06:34 AM

Raleigh, N.C.-based CRO  INC Research added electronic patient reported outcomes (ePRO) services to its offerings through a partnership with ePRO provider invivodata. Prior to the formation of the strategic partnership, the two companies collaborated on multiple international clinical trials.

More... »

Quintiles Expands Phase I Capacity in London

Thursday, March 11, 2010 07:38 AM

Quintiles expanded its London-based phase I facility by 35 beds, bringing the total number of phase I beds in London to 105 and globally to 385. The CRO said this number will increase even further later this year as a result of the planned opening of a phase I unit in Hyderabad, India. That facility will initially have 50 beds with capacity for 100.

More... »

Kendle to Open Third Office in India

Wednesday, March 10, 2010 06:54 AM

Kendle plans to open a new facility in India by the middle of April. The new unit will be based in a Special Economic Zone (SEZ) in the upcoming Ahmedabad-Gandhinagar Knowledge Corridor. The Indian government has established SEZs throughout the country to increase foreign investment and business.

More... »

MDS Completes Sale of Discovery, Preclinical Portion of CRO

Tuesday, March 9, 2010 06:07 AM

MDS completed its sale of the discovery and preclinical business of MDS Pharma Services, the company’s contract research organization (CRO).  Under the terms of the deal, CRO Ricerca Biosciences of Concord, Ohio, acquired facilities in Bothell, Wash.; Lyon, France; and Taipei, Taiwan. Those facilities have 600 employees.

More... »

University of Oklahoma, Sarah Cannon Partner on Early-Stage Cancer Research

Monday, March 8, 2010 06:43 AM

The University of Oklahoma’s OU Cancer Institute (OUCI) is partnering with strategic research organization Sarah Cannon Research Institute (SCRI) to expand the school’s early-phase oncology clinical trials program.

More... »

Clinical Trial Activity in Russia Dipped in 2009

Friday, March 5, 2010 06:56 AM

According to Russia-based contract research organization (CRO) Synergy Research Group’s Annual Orange Report, Russia’s regulatory agency Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (RosZdravNadzor, RZN) approved 577 new clinical trials during 2009, 6% fewer than in 2008. Sixty percent, or 348 of the new studies, were multinational multi-center trials, down 4% from 2008.

More... »

WuXi Partners with Janssen to Meet GLP Standards in China Lab

Thursday, March 4, 2010 06:10 AM

Chinese CRO WuXi PharmaTech expanded its strategic collaboration with Johnson & Johnson Pharmaceutical Research and Development(a division of Janssen Pharmaceutica) to provide preclinical services to Janssen and to eventually offer Good Laboratory Practice (GLP) toxicology services at WuXi’s facility in Suzhou, China.

More... »

PPD to Invest $19M in Ireland Lab

Wednesday, March 3, 2010 11:07 AM

PPD is investing up to $19 million to develop a new 18,000-square-foot analytical testing laboratory and clinical supplies business in Athlone, Ireland.

More... »